Calprotectin Levels in HIV‐Infected Patients: Correlations With Disease Progression and Intestinal Inflammation

AIDS Research and Treatment · Published 2026-01-01 · DOI 10.1155/arat/5543700

Authors being retrieved — see the publisher record. https://doi.org/10.1155/arat/5543700

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Barriers to Care for Newly Diagnosed HIV Patients: Insights From a Single‐Centre Study · AIDS Research and Treatment · 2025 · Same journal
Longitudinal Weight Gain Trajectories After Initiation of Dolutegravir‐Based Antiretroviral Therapy: A Retrospective Cohort Study · AIDS Research and Treatment · 2026 · Same journal
Magnitude, Determinants, and Coping Strategies of Food Insecurity Among People Living With HIV/AIDS in Eastern Ethiopia · AIDS Research and Treatment · 2025 · Same journal
Magnitude of Depression and Associated Factors in Women Living With HIV in Northwest, Ethiopia: Mediation Analysis · AIDS Research and Treatment · 2025 · Same journal
Perspectives on the Impacts of a Food Support Program on the Well‐Being of People Living With HIV (PLHIV) and on Antiretroviral Therapy (ART) in Khomas Region, Namibia · AIDS Research and Treatment · 2026 · Same journal
Advances in HIV Treatment and Vaccine Development: Emerging Therapies and Breakthrough Strategies for Long‐Term Control · AIDS Research and Treatment · 2025 · Same journal
Prevalence and Factors Influencing Antiretroviral Therapy (ART) Nonadherence in Men During Different Stages of the Life Course: A Case Study in Greater Gaborone, Botswana · AIDS Research and Treatment · 2025 · Same journal
Incidence of Hyperlipidemia among Adults Initiating Antiretroviral Therapy in the HIV Outpatient Study (HOPS), USA, 2007–2021 · AIDS Research and Treatment · 2023 · Same journal
Understanding Antiretroviral Therapy Adherence in Children With HIV: A Review of Barriers and Strategies · AIDS Research and Treatment · 2026 · Same journal
BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV‐Infected Patients · AIDS Research and Treatment · 2025 · Same journal